<?xml version="1.0" encoding="ISO-8859-1"?>

<rss version="2.0">
<channel>
<title>Ventria Bioscience - PRWeb Press Release Group</title>
<link>http://www.rsspad.com/rss2/12678.xml</link>
<description>Ventria Bioscience - Powered by PRWeb and RSSPad</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
         <title>Leading Pediatric Expert Supports Improvements in Child Health Products</title>
         <link>http://www.prweb.com/releases/2006/10/prweb458678.htm</link><description>   <![CDATA[ <P>A presentation published in a new volume of the Nestle Nutrition Workshop Series, &#8220;Protein and Energy Requirements in Infancy and Childhood&#8221; describes the health benefits of breast milk and also supports the addition of two recombinant human breast milk proteins to child health and nutrition products. (PRWeb Oct 24, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/10/prweb458678.htm">http://www.prweb.com/releases/2006/10/prweb458678.htm</a></P>]]>
                </description>
<pubDate>Tue, 24 Oct 2006 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2006/10/prweb458678.htm</guid> </item>
<item>
         <title>Ventria Bioscience Announces Third Bioprocessing Product: Cellastim&amp;#8482;, Animal-Free Recombinant Human Serum Albumin</title>
         <link>http://www.prweb.com/releases/2006/07/prweb411101.htm</link><description>   <![CDATA[ <P>This press release announces a new bioprocessing product for Ventria Bioscience called Cellastim.  Cellastim is recombinant human serum albumin for use in cell culture. (PRWeb Jul 13, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/07/prweb411101.htm">http://www.prweb.com/releases/2006/07/prweb411101.htm</a></P>]]>
                </description>
<pubDate>Thu, 13 Jul 2006 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2006/07/prweb411101.htm</guid> </item>
<item>
         <title>A Breakthrough For Second Leading Killer of Children Under Five &amp;#8211; A Medical Food* for Acute Diarrhea</title>
         <link>http://www.prweb.com/releases/2006/05/prweb379201.htm</link><description>   <![CDATA[ <P>The results of a recent study show that adding Lactiva and Lysomin to oral rehydration solution helps to reduce the duration and recurrence of acute diarrhea in children. (PRWeb May 1, 2006)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2006/05/prweb379201.htm">http://www.prweb.com/releases/2006/05/prweb379201.htm</a></P>]]>
                </description>
<pubDate>Mon, 01 May 2006 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2006/05/prweb379201.htm</guid> </item>
<item>
         <title>Melvin D. Booth and Dean L. Hubbard, Ph.D. Join Ventria’s Board of Directors</title>
         <link>http://www.prweb.com/releases/2005/01/prweb203014.htm</link><description>   <![CDATA[ <P>Ventria Bioscience, a privately held biopharmaceutical company that is leading the development of plant-made pharmaceuticals, announced today that Melvin D. Booth, former President of MedImmune, and Dean L. Hubbard, Ph.D., President of Northwest Missouri State University, have joined the company’s Board of Directors. (PRWeb Jan 28, 2005)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2005/01/prweb203014.htm">http://www.prweb.com/releases/2005/01/prweb203014.htm</a></P>]]>
                </description>
<pubDate>Fri, 28 Jan 2005 08:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2005/01/prweb203014.htm</guid> </item>
<item>
         <title>Ventria Bioscience Initiates Seventh Straight Year of Production</title>
         <link>http://www.prweb.com/releases/2004/12/prweb191613.htm</link><description>   <![CDATA[ <P>Plant-made pharmaceutical company developing health solutions for the global community. (PRWeb Dec 23, 2004)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2004/12/prweb191613.htm">http://www.prweb.com/releases/2004/12/prweb191613.htm</a></P>]]>
                </description>
<pubDate>Thu, 23 Dec 2004 08:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2004/12/prweb191613.htm</guid> </item>
</channel>
</rss>